Pura Vida Investments, LLC 的 Form 4/A 修正申報
修正Insight Molecular Diagnostics Inc.（IMDX），2022/4/29 申報
- 申報編號
- 0001829126-22-009190
- 申報時間
- 2022/4/29 16:33 ET
- 交易日
- 2022/4/14
- 申報延遲
- 15 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2022/4/18
這份申報列了 8 筆非衍生性交易、4 筆衍生性交易。公開市場買進合計 $788.8 萬。交易後 15 天申報。
這份申報後來被修正申報 0001209191-22-039690（2022/6/28）取代，網站的交易表改用修正後的版本。
這份修正申報取代了 0001829126-22-008372（2022/4/18 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Pura Vida Investments, LLCCIK 0001590144 | 持股 10% 以上大股東 |
| Kamen EfremCIK 0001789193 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/4/14 | Common Stock | P買進取得 | +1,665,898 | $1.33 | +$2,219,809.09 | 7,350,447 | 間接 | |
| 2022/4/14 | Common Stock | P買進取得 | +30,790 | $1.23 | +$37,779.33 | 7,381,237 | 間接 | |
| 2022/4/14 | Common Stock | P買進取得 | +92,370 | $1.26 | +$116,386.2 | 7,473,607 | 間接 | |
| 2022/4/14 | Common Stock | P買進取得 | +1,916,419 | $1.33 | +$2,553,628.32 | 8,455,823 | 間接 | |
| 2022/4/14 | Common Stock | P買進取得 | +19,210 | $1.23 | +$23,570.67 | 8,475,033 | 間接 | |
| 2022/4/14 | Common Stock | P買進取得 | +57,630 | $1.26 | +$72,613.8 | 8,532,663 | 間接 | |
| 2022/4/14 | Common Stock | P買進取得 | +767,952 | $1.33 | +$1,023,296.04 | 767,952 | 間接 | |
| 2022/4/14 | Common Stock | P買進取得 | +1,381,438 | $1.33 | +$1,840,766.14 | 1,381,438 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Each share of common stock was purchased together with one warrant to purchase 0.5 shares of common stock at a combined offering price of $1.3325.
表 II 有 4 筆交易的價格引用這則附註。
- F2
Shares reported herein are owned by Pura Vida Master Fund, Ltd. (the "Pura Vida Master Fund"), Pura Vida X Fund LP (the "Pura Vida X Fund"), Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust"), and certain separately managed accounts (the "Managed Accounts," collectively the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
- F3
By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.
- F4
The Warrants are subject to an ownership blocker provision that prevents the holder from exercising the Warrants if it would beneficially hold more than 19.99% of the common stock following such exercise.
備註
This amendment to the Form 4 is being filed solely to correct the address reported for Efrem Kamen.